| answer text |
<p>The cost of respiratory medicines to the National Health Service, by primary and
secondary care, in England from years 2012 to 2016 is shown in the following table.</p><p>
</p><table><tbody><tr><td><p> </p></td><td><p>Primary Care Net Ingredient Cost (£)</p></td><td><p>Secondary
Care Cost (£)</p></td><td><p>Total Cost (£)</p></td></tr><tr><td><p>2012</p></td><td><p>1,009,505,840</p></td><td><p>39,842,049</p></td><td><p>1,049,347,889</p></td></tr><tr><td><p>2013</p></td><td><p>1,020,038,047</p></td><td><p>39,938,913</p></td><td><p>1,059,976,960</p></td></tr><tr><td><p>2014</p></td><td><p>1,032,783,044</p></td><td><p>38,983,420</p></td><td><p>1,071,766,464</p></td></tr><tr><td><p>2015</p></td><td><p>1,044,951,211</p></td><td><p>38,600,943</p></td><td><p>1,083,552,154</p></td></tr><tr><td><p>2016</p></td><td><p>1,034,877,082</p></td><td><p>38,547,801</p></td><td><p>1,073,424,883</p></td></tr></tbody></table><p>Source:
Prescription Cost Analysis; 2016 QuintilesIMS: Hospital Pharmacy Audit Index</p><p>
</p><p>These figures do not include costs for treating respiratory infections or cancers,
as the medicines required (antibiotics and chemotherapy) are used for other therapy
areas and are not specific to respiratory disease. These costs are at list prices,
and discounts achieved by hospitals and community pharmacy have not been included.</p>
|
|
